Moderating the relationship between diabetes distress and mastery: the role of depression and empowerment
Open Access
- 1 March 2021
- journal article
- research article
- Published by Taylor & Francis in Psychology, Health & Medicine
- Vol. 27 (4) , 838-847
Abstract
Type 2 diabetes is a chronic condition primarily self-managed by the individual. Mastery is a protective factor linked to better control of chronic conditions, effective self-management and improved medication adherence. Mastery appears increasingly important as treatment regimens and self-management demands become more complex and burdensome. Diabetes distress negatively impacts self-management, glycaemic control and treatment adherence. Understanding the relationship between diabetes distress and mastery may provide opportunities to improve condition management and adherence . This relationship may be impacted by other factors affecting the individual's perceived sense of control over their condition. This study examined the role of diabetes empowerment and depression in the relationship between diabetes distress and mastery. Data were drawn from a randomised controlled trial of 131 adults with type 2 diabetes transitioning to injection therapy. Participants completed measures of diabetes distress , mastery , depression and empowerment . Diabetes distress and depression were negatively associated with mastery, whilst diabetes empowerment was positively associated . A significant interaction effect (b = .024, t(112) = 3.79, p = <.005) confirmed the relationship between diabetes distress and mastery was moderated by depression. Findings highlight the additive deleterious effects of depression. Interventions to improve mastery among those living with type 2 diabetes should address diabetes distress and depression to optimise outcomes.Keywords
Funding Information
- HSC Research and Development Division of the Public Health Agency, Northern Ireland (grant number: EAT/4909/13)
This publication has 32 references indexed in Scilit:
- The Longitudinal Association between Depressive Symptoms and Initiation of Insulin Therapy in People with Type 2 Diabetes in Primary CarePLOS ONE, 2013
- Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy studyDiabetic Medicine, 2012
- Toward a more complete understanding of the effects of personal mastery on cardiometabolic health.Health Psychology, 2011
- Validation of the Chinese Version of the Problem Areas in Diabetes (PAID-C) ScaleDiabetes Care, 2009
- Anxiety and depression symptoms in patients with diabetesDiabetic Medicine, 2009
- Diabetes education and self-management for ongoing and newly diagnosed (DESMOND): Process modelling of pilot studyPatient Education and Counseling, 2006
- Measures of self-efficacy, helplessness, mastery, and control: The Arthritis Helplessness Index (AHI)/Rheumatology Attitudes Index (RAI), Arthritis Self-Efficacy Scale (ASES), Children's Arthritis Self-Efficacy Scale (CASE), Generalized Self-Efficacy Scale (GSES), Mastery Scale, Multi-Dimensional Health Locus of Control Scale (MHLC), Parent's Arthritis Self-Efficacy Scale (PASE), Rheumatoid Arthritis Self-Efficacy Scale (RASE), and Self-Efficacy Scale (SES)Arthritis & Rheumatism, 2003
- The validity of the Hospital Anxiety and Depression ScaleJournal of Psychosomatic Research, 2002
- Assessment of Diabetes-Related DistressDiabetes Care, 1995
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983